Patents by Inventor Charles Swerdlow

Charles Swerdlow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11484718
    Abstract: An ICD multimode system comprises a microcontroller or FPGA having a memory, a differentially driven phased array amplifier, one or more sensors, and a wireless transmitter/receiver. Based upon sensor data and demand criteria programmed into the memory, the system provides late systolic impulse (LSI) therapy to treat congestive heart failure (CHF) and ventricle level-shifting (VLS) therapy to block unwanted PVCs to prevent VT or VF dynamically and use a phased array amplifier therapy to accurately manage CRT. An external echocardiogram and ultrasound system adjusts the therapies administered based upon sensor and demand data in real time to allow a patient's heart to function at a level of improved performance and increase ejection fraction EF.
    Type: Grant
    Filed: January 24, 2022
    Date of Patent: November 1, 2022
    Assignee: RUSE TECHNOLOGIES, LLC
    Inventors: Richard B. Ruse, Charles Swerdlow, Mark W. Kroll, Scott Bohanan
  • Publication number: 20220233868
    Abstract: An ICD multimode system comprises a microcontroller or FPGA having a memory, a differentially driven phased array amplifier, one or more sensors, and a wireless transmitter/receiver. Based upon sensor data and demand criteria programmed into the memory, the system provides late systolic impulse (LSI) therapy to treat congestive heart failure (CHF), ventricle level-shifting (VLS) therapy to block unwanted PVCs to prevent VT or VF, and cardiac resynchronization therapy (CRT) that adjusts LV and RV contraction synchronization based upon timing. An integrated echocardiogram and ultrasound system automatically adjusts the therapies administered based upon sensor and demand data in real time to allow a patient's heart to function at a level of improved performance and efficiency.
    Type: Application
    Filed: January 24, 2022
    Publication date: July 28, 2022
    Inventors: RICHARD B. RUSE, CHARLES SWERDLOW, MARK W. KROLL, SCOTT BOHANAN
  • Patent number: 10543364
    Abstract: Methods and systems for identifying dislodgement of an electrode, operably coupled to an implanted medical device, from fixation with the endocardium of a chamber of the heart of a patient can include obtaining a test electrogram, and measuring at least two parameters indicating a cavitary electrogram and taking an action, such as generating an electrode dislodgement alert and/or configuring the implanted medical device to disable therapy, when the cavitary electrogram is indicated. In embodiments, the two parameters include a test positive component magnitude and a test negative component magnitude. In embodiments, the test component magnitudes are compared to baseline component magnitudes determined from a baseline electrogram.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: January 28, 2020
    Assignee: Lambda Nu Technology LLC
    Inventor: Charles Swerdlow
  • Patent number: 10118031
    Abstract: Scientific and medical system circuitry for diagnosis of implantable cardioverter defibrillator (ICD) lead conductor anomalies, in particular conductor migration and externalization within an ICD implantable cardiac lead. The system determines an “imaginary” component of the high frequency transmission line impedance having certain spectral changes that correspond to radially outward movements or local externalization of a conductor within a lead body allowing for the detection of conductor migration and small insulation failures.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: November 6, 2018
    Assignee: Lambda Nu Technology LLC
    Inventors: Mark Kroll, Charles Swerdlow, Daniel T. Kollmann
  • Publication number: 20180289952
    Abstract: Methods and systems for identifying dislodgement of an electrode, operably coupled to an implanted medical device, from fixation with the endocardium of a chamber of the heart of a patient can include obtaining a test electrogram, and measuring at least two parameters indicating a cavitary electrogram and taking an action, such as generating an electrode dislodgement alert and/or configuring the implanted medical device to disable therapy, when the cavitary electrogram is indicated. In embodiments, the two parameters include a test positive component magnitude and a test negative component magnitude. In embodiments, the test component magnitudes are compared to baseline component magnitudes determined from a baseline electrogram.
    Type: Application
    Filed: August 16, 2017
    Publication date: October 11, 2018
    Inventor: Charles Swerdlow
  • Patent number: 9827416
    Abstract: A method and apparatus to detect anomalies in the conductors of leads attached to implantable medical devices based on the dynamical electrical changes these anomalies cause. In one embodiment, impedance is measured for weak input signals of different applied frequencies, and a conductor anomaly is detected based on differences in impedance measured at different frequencies. In another embodiment, a transient input signal is applied to the conductor, and an anomaly is identified based on parameters related to the time course of the voltage or current response, which is altered by anomaly-related changes in capacitance and inductance, even if resistance is unchanged. The method may be implemented in the implantable medical device or in a programmer used for testing leads.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: November 28, 2017
    Assignee: Lambda Nu Technology LLC
    Inventor: Charles Swerdlow
  • Publication number: 20150088213
    Abstract: A method and apparatus to detect anomalies in the conductors of leads attached to implantable medical devices based on the dynamical electrical changes these anomalies cause. In one embodiment, impedance is measured for weak input signals of different applied frequencies, and a conductor anomaly is detected based on differences in impedance measured at different frequencies. In another embodiment, a transient input signal is applied to the conductor, and an anomaly is identified based on parameters related to the time course of the voltage or current response, which is altered by anomaly-related changes in capacitance and inductance, even if resistance is unchanged. The method may be implemented in the implantable medical device or in a programmer used for testing leads.
    Type: Application
    Filed: August 28, 2014
    Publication date: March 26, 2015
    Inventor: Charles Swerdlow
  • Publication number: 20150005862
    Abstract: Scientific and medical system circuitry for diagnosis of implantable cardioverter defibrillator (ICD) lead conductor anomalies, in particular conductor migration and externalization within an ICD implantable cardiac lead. The system determines an “imaginary” component of the high frequency transmission line impedance having certain spectral changes that correspond to radially outward movements or local externalization of a conductor within a lead body allowing for the detection of conductor migration and small insulation failures.
    Type: Application
    Filed: March 11, 2014
    Publication date: January 1, 2015
    Inventors: Mark Kroll, Charles Swerdlow
  • Patent number: 8831722
    Abstract: A method for accurately determining timing points for T-wave shocks is particularly useful in a system for determining a cardiac shock strength in an implantable cardioverter defibrillator (ICD. The method involves acquiring at least one first signal, acquiring at least a second signal, comparing the signals, and selecting a timing point with the T-wave of the signal. The first and second signals may be two different aspects of a single electrogram, first and second electrograms, or a combination thereof. Comparison preferably involves signal alignment and qualitative analysis.
    Type: Grant
    Filed: April 3, 2012
    Date of Patent: September 9, 2014
    Assignee: Imperception, Inc.
    Inventor: Charles Swerdlow
  • Patent number: 8825158
    Abstract: A method and apparatus to detect anomalies in the conductors of leads attached to implantable medical devices based on the dynamical electrical changes these anomalies cause. In one embodiment, impedance is measured for weak input signals of different applied frequencies, and a conductor anomaly is detected based on differences in impedance measured at different frequencies. In another embodiment, a transient input signal is applied to the conductor, and an anomaly is identified based on parameters related to the time course of the voltage or current response, which is altered by anomaly-related changes in capacitance and inductance, even if resistance is unchanged. The method may be implemented in the implantable medical device or in a programmer used for testing leads.
    Type: Grant
    Filed: August 25, 2010
    Date of Patent: September 2, 2014
    Assignee: Lamda Nu, LLC
    Inventor: Charles Swerdlow
  • Publication number: 20130261686
    Abstract: A method for accurately determining timing points for T-wave shocks is particularly useful in a system for determining a cardiac shock strength in an implantable cardioverter defibrillator (ICD. The method involves acquiring at least one first signal, acquiring at least a second signal, comparing the signals, and selecting a timing point with the T-wave of the signal. The first and second signals may be two different aspects of a single electrogram, first and second electrograms, or a combination thereof. Comparison preferably involves signal alignment and qualitative analysis.
    Type: Application
    Filed: April 3, 2012
    Publication date: October 3, 2013
    Inventor: Charles Swerdlow
  • Patent number: 8150510
    Abstract: A method for accurately determining timing points for T-wave shocks is particularly useful in a system for determining a cardiac shock strength in an implantable cardioverter defibrillator (ICD. The method involves acquiring at least one first signal, acquiring at least a second signal, comparing the signals, and selecting a timing point with the T-wave of the signal. The first and second signals may be two different aspects of a single electrogram, first and second electrograms, or a combination thereof. Comparison preferably involves signal alignment and qualitative analysis.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: April 3, 2012
    Assignee: Imperception, Inc.
    Inventor: Charles Swerdlow
  • Publication number: 20110054554
    Abstract: A method and apparatus to detect anomalies in the conductors of leads attached to implantable medical devices based on the dynamical electrical changes these anomalies cause. In one embodiment, impedance is measured for weak input signals of different applied frequencies, and a conductor anomaly is detected based on differences in impedance measured at different frequencies. In another embodiment, a transient input signal is applied to the conductor, and an anomaly is identified based on parameters related to the time course of the voltage or current response, which is altered by anomaly-related changes in capacitance and inductance, even if resistance is unchanged. The method may be implemented in the implantable medical device or in a programmer used for testing leads.
    Type: Application
    Filed: August 25, 2010
    Publication date: March 3, 2011
    Inventor: Charles Swerdlow
  • Publication number: 20080051841
    Abstract: A method for determining a cardiac shock strength, for example the programmed first-therapeutic shock strength of an implantable cardioverter defibrillator (ICD), including the steps of sensing a change in a T-wave of an electrogram with respect to time such as the maximum of the first derivative of a T-wave of an electrogram; delivering a test shock by (i) delivering a test shock at a test-shock strength and at a test-shock time relating to the maximum of the first derivative of the T-wave with respect to time; and (ii) sensing for cardiac fibrillation. If fibrillation is not sensed, test-shock delivery is repeated at the same test-shock strength and at specific, different test-shock times relating to the maximum of the first derivative of the T-wave. If fibrillation is still not sensed, the shock strength is decreased and test shocks are repeated at the same specific test shock times relative to the maximum of the first derivative of the T-wave.
    Type: Application
    Filed: August 21, 2007
    Publication date: February 28, 2008
    Inventors: Charles Swerdlow, Kalyanam Shivkumar
  • Publication number: 20080033494
    Abstract: A method for accurately determining timing points for T-wave shocks is particularly useful in a system for determining a cardiac shock strength in an implantable cardioverter defibrillator (ICD. The method involves acquiring at least one first signal, acquiring at least a second signal, comparing the signals, and selecting a timing point with the T-wave of the signal. The first and second signals may be two different aspects of a single electrogram, first and second electrograms, or a combination thereof. Comparison preferably involves signal alignment and qualitative analysis.
    Type: Application
    Filed: May 18, 2007
    Publication date: February 7, 2008
    Inventor: Charles Swerdlow
  • Publication number: 20060247687
    Abstract: A method and apparatus for validating a cardiac pacing pulse train preceding a T-shock. Validation of the pacing pulse train includes verifying capture of at least the last pacing pulse of the pulse train and verifying that intrinsic ventricular events are not sensed during a pacing train interval that includes at least the interval between the last pacing pulse and a scheduled T-shock delivery. Capture verification may include sensing an event during an ER sensing window, morphological analysis of a sensed event, and analysis of the temporal relationship between sensed events occurring on different EGM sources. The scheduled T-shock is delivered in response to a valid pacing pulse train. A response to an invalid pacing pulse train may include any of an invalid pacing train notification, withholding a scheduled T-shock, extension of the pacing train, repeating the pacing train, or adjusting the pacing pulse train parameters.
    Type: Application
    Filed: April 28, 2005
    Publication date: November 2, 2006
    Inventors: Charles Swerdlow, William Havel